(BIO) Bio-Rad Laboratories - Performance -12% in 12m
Compare BIO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-49.89%
#31 in Group
Rel. Strength
32.61%
#5414 in Universe
Total Return 12m
-11.96%
#17 in Group
Total Return 5y
-45.30%
#27 in Group
P/E -
(?) Percentile in Group
P/E Forward 26.7
76th Percentile in Group
PEG 1.19
50th Percentile in Group
FCF Yield 4.13%
62th Percentile in Group
12m Total Return: BIO (-12%) vs XLV (0.3%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
-11.6% | -21.5% | 44.2% | 23.5 | 18.4 | 1.68 | 58.4% | 7.8% |
| RVTY NYSE Revvity |
-12.1% | -7.4% | 7.42% | 39 | 18.2 | 0.64 | -63.9% | -30.6% |
| TECH NASDAQ Bio-Techne |
-16.2% | -19.5% | -1.48% | 51.8 | 22.6 | 1.07 | -31.9% | -5.85% |
| SHC NASDAQ Sotera Health |
-6.5% | -1.46% | -55.6% | 65.6 | 20.2 | 1.68 | -43.6% | - |
Performance Comparison: BIO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for BIO
| Total Return (including Dividends) | BIO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.89% | -4.97% | -4.31% |
| 3 Months | -32.39% | -6.08% | -7.85% |
| 12 Months | -11.96% | 0.26% | 10.76% |
| 5 Years | -45.30% | 47.01% | 106.31% |
| Trend Score (consistency of price movement) | BIO | XLV | S&P 500 |
| 1 Month | 22.6% | -54.4% | -35.6% |
| 3 Months | -91.5% | -66.1% | -89.7% |
| 12 Months | -4.60% | -12% | 58.3% |
| 5 Years | -81.8% | 90% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #16 | 3.24% | 2.53% |
| 3 Month | #32 | -28.0% | -26.6% |
| 12 Month | #18 | -12.2% | -20.5% |
| 5 Years | #27 | -62.8% | -73.5% |
FAQs
Does BIO Bio-Rad Laboratories outperforms the market?
No,
over the last 12 months BIO made -11.96%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.26%.
Over the last 3 months BIO made -32.39%, while XLV made -6.08%.
Over the last 3 months BIO made -32.39%, while XLV made -6.08%.
Performance Comparison BIO vs Indeces and Sectors
BIO vs. Indices BIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.72% | 2.42% | -19.9% | -22.7% |
| US NASDAQ 100 | QQQ | -6.68% | 2.35% | -19.9% | -24.0% |
| US Dow Jones Industrial 30 | DIA | -2.65% | 3.89% | -20.2% | -18.9% |
| German DAX 40 | DAX | -2.06% | 1.92% | -38.4% | -35.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.81% | 1.61% | -18.5% | -20.6% |
| Hongkong Hang Seng | HSI | -2.45% | 0.99% | -21.8% | -26.0% |
| India NIFTY 50 | INDA | 2.71% | -3.45% | -21.5% | -13.8% |
| Brasil Bovespa | EWZ | -4.47% | -3.86% | -24.4% | -6.46% |
BIO vs. Sectors BIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.58% | 3.69% | -28.7% | -34.4% |
| Consumer Discretionary | XLY | -7.07% | 2.15% | -23.1% | -26.3% |
| Consumer Staples | XLP | 2.74% | -4.64% | -25.3% | -21.5% |
| Energy | XLE | -1.37% | 9.74% | -17.5% | -0.03% |
| Financial | XLF | -2.76% | 2.89% | -28.0% | -31.3% |
| Health Care | XLV | -1.70% | 3.08% | -17.9% | -12.2% |
| Industrial | XLI | -2.89% | 2.18% | -20.3% | -18.9% |
| Materials | XLB | -1.47% | 2.62% | -13.0% | -6.62% |
| Real Estate | XLRE | 0.11% | 0.02% | -17.8% | -27.1% |
| Technology | XLK | -8.53% | 2.63% | -15.1% | -18.2% |
| Utilities | XLU | -0.57% | -3.57% | -23.0% | -32.4% |
| Aerospace & Defense | XAR | -4.28% | -1.59% | -31.2% | -38.9% |
| Biotech | XBI | -3.85% | 5.95% | -6.84% | -9.71% |
| Homebuilder | XHB | -2.97% | 4.13% | -4.95% | -3.99% |
| Retail | XRT | -1.93% | 1.04% | -15.8% | -8.34% |